<h4>Aim</h4>Glioblastoma (GBM), a rare, highly aggressive and chemoresistant brain cancer, exhibits profound metabolic plasticity that relies, in part, on aberrant transforming growth factor-β (TGF-β) signaling. This evidence concerns the gene TGFB1 and brain cancer.